ABL Europe to manufacture Themis SARS-CoV-2 vaccine in France
May 11, 2020 -- Biopharmaceutical company Themis and contract development and manufacturing organization ABL Europe announced that they have signed an agreement to manufacture a SARS-CoV-2 vaccine candidate in preparation for clinical trials. Read More
Sorrento, Mount Sinai to develop targeted SARS-CoV-2 antibody treatment
May 8, 2020 -- Sorrento Therapeutics and Mount Sinai Health System have joined forces to develop an antibody therapy called COVI-Shield to treat COVID-19. Read More
Gladstone opens institutes to study unsolved diseases
May 8, 2020 -- Gladstone Institutes plans to launch two new biomedical research institutes in San Francisco to broaden its impact on unsolved diseases, including COVID-19. Read More
PerkinElmer Q1 revenues edge up, profit edges down
May 8, 2020 -- In financial results for the first quarter, PerkinElmer saw revenues grow slightly, but net income slipped. Read More
Caribou, MaxCyte enter CRISPR license agreement
May 7, 2020 -- Caribou Biosciences and MaxCyte have announced a clinical and commercial license agreement for the development of Carbiou's CAR-T cell therapy program. Read More
Thermo Fisher launches SARS-CoV-2 GlobalAccess Sequencing Program
May 7, 2020 -- Thermo Fisher Scientific is providing 50 units of its Ion Torrent Genexus system at a subsidized price to support global COVID-19 research as part of its SARS-CoV-2 GlobalAccess Sequencing Program. Read More
Certara, DMTC study preventative use of chloroquine for COVID-19
May 7, 2020 -- Certara and DMTC have entered into a research collaboration to evaluate the preventative use of chloroquine in healthcare workers at risk of infection from SARS-CoV-2, the coronavirus strain responsible for COVID-19. Read More
BD revenues edge up for 2nd quarter
May 7, 2020 -- Becton Dickinson (BD) saw its revenues grow slightly for the second quarter, but the company withdrew its previously issued guidance due to fallout from the COVID-19 pandemic. Read More
Avectas, ONK to develop cancer cell therapy
May 6, 2020 -- Avectas has exclusively licensed a chimeric antigen receptor-directed natural killer cell therapy from ONK Therapeutics for the treatment of B-cell malignancies such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Read More
Thermo Fisher Scientific optimizes NGS platform for COVID-19
May 6, 2020 -- To expedite genomic analysis of COVID-19 resurgent strains, Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 research panel for use on the Ion Torrent Genexus system. Read More
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter